Best Practice & Research Clinical Rheumatology
Volume 20, Issue 5 , Pages 879-896, October 2006

Is IL-1 a good therapeutic target in the treatment of arthritis?

  • Danielle Burger, PhD (Senior Researcher)

      Affiliations

    • Corresponding Author InformationCorresponding author: Tel.: +41 22 372 93 76; Fax: +41 22 372 93 69.
  • Cem Gabay, MD (Professor, Head of the Division of Rheumatology)

Clinical Immunology Unit, Division of Immunology and Allergy, Department of Internal Medicine, University Hospital, 24 rue Micheli-du-Crest, CH-1211 Geneva 14, Switzerland

Division of Rheumatology, Department of Internal Medicine, University Hospital of Geneva & Department of Pathology and Immunology, University of Geneva School of Medicine, Switzerland

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-6942(06)00078-7

doi:10.1016/j.berh.2006.06.004

Best Practice & Research Clinical Rheumatology
Volume 20, Issue 5 , Pages 879-896, October 2006

Article Tools